You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics in the development group and validation group

From: Pulmonary infection after cardiopulmonary bypass surgery in children: a risk estimation model in China

Variable (%) Development group(n = 1776) Validation group(n = 395)
PI (n = 580) non-PI (n = 1196) P Value PI (n = 128) non-PI (n = 267) P Value
Sex    0.782    0.624
Male 312(53.8) 635 (53.1)   70 (54.7) 139 (52.1)  
Female 268 (46.2) 561 (46.9)   58 (45.3) 128 (47.9)  
Age (month)    <.001    <.001
< 6 110 (19.0) 65 (5.4)   24 (18.7) 10 (3.8)  
6–11.99 187 (32.2) 185 (15.5)   34 (26.6) 46 (17.2)  
12–23.99 154 (26.6) 271 (22.7)   48 (37.5) 70 (26.2)  
> = 24 129 (22.2) 675 (56.4)   22 (17.2) 141 (52.8)  
Weight (kg)    <.001    <.001
< 5 63 (10.9) 21 (1.8)   17 (13.3) 6 (2.3)  
5–7.99 231 (39.8) 240 (20.0)   55 (43.0) 54 (20.2)  
8–13.99 230 (39.7) 520 (43.5)   50 (39.1) 134 (50.2)  
> = 14 56 (9.6) 415 (34.7)   6 (4.6) 73 (27.3)  
PAH    0.251    0.965
YES 249 (42.9) 548 (45.8)   51 (39.8) 107 (40.1)  
NO 331 (57.1) 648 (54.2)   77 (60.2) 160 (59.9)  
RACHS-1    <.001    <.001
<=2 280 (48.3) 1106 (92.5)   56 (43.8) 256 (95.9)  
> = 3 300 (51.7) 90 (7.5)   72 (56.2) 11 (4.1)  
Preoperative hospital stay (min)    <.001    <.001
< 125 156 (26.9) 643 (53.8)   31 (24.2) 132 (49.4)  
125–174.99 179 (30.9) 365 (30.5)   44 (34.4) 78 (29.2)  
175–224.99 89 (15.3) 115 (9.6)   21 (16.4) 32 (12.0)  
> = 225 156 (26.9) 73 (6.1)   32 (25.0) 25 (9.4)  
Anaesthesia time (min)    <.001    <.001
< 190 41 (7.1) 353 (29.5)   11 (8.6) 92 (34.5)  
190–239.99 202 (34.8) 638 (53.3)   52 (40.6) 144 (53.9)  
> = 240 337 (58.1) 205 (17.2)   65 (50.8) 31 (11.6)  
Cardiopulmonary bypass time (min)    <.001    <.001
< 65 68 (11.7) 555 (46.4)   18 (14.1) 147 (55.1)  
65–94.99 184 (31.7) 519 (43.4)   40 (31.2) 101 (37.8)  
95–134.99 218 (37.6) 105 (8.8)   47 (36.7) 18 (6.7)  
> = 135 110 (19.0) 17 (1.4)   23 (18.0) 1 (0.4)  
Aortic occlusion time (min)    <.001    <.001
< 25 40 (6.9) 301 (25.1)   9 (7.1) 79 (29.6)  
25–54.99 239 (41.2) 770 (64.4)   51 (39.8) 164 (61.4)  
> = 55 301 (51.9) 125 (10.5)   68 (53.1) 24 (9.0)  
Operation time (min)    <.001    <.001
< 110 3 (0.5) 64 (5.4)   1 (0.8) 22 (8.2)  
110–179.99 248 (42.8) 910 (76.0)   61 (47.7) 220 (82.4)  
> = 180 329 (56.7) 222 (18.6)   66 (51.65) 25 (9.4)  
Intraoperative blood transfusion    <.001    <.001
YES 264 (45.5) 166 (13.9)   59 (46.1) 215 (80.5)  
NO 316 (54.5) 1030 (86.1)   69 (53.9) 52 (19.5)  
Preoperative total protein content (g/L)    0.03    0.038
< 59 99 (17.1) 158 (13.2)   18 (14.1) 20 (7.5)  
> = 59 481 (82.9) 1038 (86.8)   110 (85.9) 247 (92.5)  
Preoperative albumin (g/L)    0.509    0.486
< 39 15 (2.6) 25 (2.1)   5 (3.9) 7 (2.6)  
> = 39 565 (97.4) 1171 (97.9)   123 (96.1) 260 (97.4)  
  1. PAH Pulmonary hypertension, PI Pulmonary infection, non-PI Non- pulmonary infection
\